A dual-light source human brain photobiomodulation device based on near-infrared LED and laser

Abstract

The present invention discloses a dual-light source human brain photobiomodulation device based on near-infrared LED and laser, including a multi-point laser unit and a multi-point LED unit. The multi-point laser unit is used to arrange a light source that outputs a near-infrared laser corresponding to a physiotherapy spectrum interval at at least one point, and the multi-point LED unit is used to arrange a light source that outputs a near-infrared light corresponding to a physiotherapy spectrum interval at at least one point. The multi-point laser unit and the multi-point LED unit both fit the outside of the human brain and have overlapping output functional areas. On the basis of the multi-point LED phototherapy module, a low-power level infrared laser light source physiotherapy module is added, which can be combined with the lesion target area position of medical imaging technology (such as CT, etc.) to assist in guiding the laser to irradiate precisely, and solves the problem of limited physiotherapy area through a multi-tentacle adjustable mechanical structure. The present invention solves the technical status quo that the irradiation area of ​​the multi-point LED is limited and it is difficult to effectively deal with the diseased tissue deep in the brain area.

Description

Technical Field

[0001] The present invention relates to the field of physical therapy devices, and in particular to a dual-light source human brain photobiomodulation device based on near-infrared LED and laser. Background Art

[0002] At present, transcranial light therapy (TLT) or transcranial photobiomodulation (tPBM) has been fully scientifically demonstrated and a certain amount of useful clinical data has been obtained. Near-infrared light (NIR light) can regulate the metabolic activity of cells by regulating the mitochondrial function, the signaling system in neurons, and the redox state inside the brain nerves. NIR light acts on the photoreceptor respiratory enzyme (cytochrome oxidase) in the cell mitochondria and can convert the energy of these NIR lights into adenosine triphosphate (ATP) to promote the repair of damaged brain cells. It has been shown that low-energy levels of NIR light entering brain cells can significantly improve the neurological symptoms caused by stroke, increase brain blood supply and play a positive role in traumatic brain injury. The transmission of low-energy levels of NIR light in human tissues and the absorption of brain cells are not accompanied by any substantial complications or major side effects. Purposefully guiding NIR light to one or more lesions in the living brain according to treatment needs can beneficially improve and prevent a variety of medically recognized neurological diseases and pathologies such as Alzheimer's disease (AD), Parkinson's disease (PD) and depression.

[0003] The lesions of brain tissues in elderly people with consciousness disorders such as Alzheimer's disease and Parkinson's disease are mainly concentrated in the prefrontal cortex, posterior cingulate cortex, precuneus, temporal lobe and hippocampus. The lesions of brain tissues are spatially characterized by continuous or discrete distribution of surface cortex and deep tissue patterns. For AD patients whose condition tends to worsen, the lesions of brain tissues change from point, surface to block in time. The light source devices of the current phototherapy equipment for the human brain are all near-infrared low-power LEDs. Due to their relatively fixed arrangement and distribution number, and the limited irradiation depth, they are only suitable for treating the local surface cortex of the brain. However, for different patients and patients with different degrees of illness, the area and shape of their brain lesions are quite different. The site of disease is a three-dimensional distribution from deep to shallow from the tissue around the hippocampus to the surface cortex of the brain, making it difficult for existing equipment to deal with deep lesions, and it is also difficult to deal with the current status of lesion treatment with random distribution of multiple points, multiple surfaces and multiple blocks. Since the therapy area is fixed, the therapy depth and range are limited, which greatly limits the therapy effect.

[0004] A dual-light source human brain photobiomodulation device based on near-infrared LED and laser is needed to solve the above problems. Summary of the invention

[0005] The present invention aims to solve the problem that the light source devices of the current photobiotherapy equipment for the human brain in the prior art are all near-infrared low-power LEDs. Due to their relatively fixed arrangement and distribution number, and the limited irradiation depth, they are only suitable for treating the local surface cortex of the brain. However, for different patients and patients with different disease severity, the area and shape of their brain lesions are quite different. The disease site is distributed in a three-dimensional manner from deep to shallow from the tissue around the hippocampus to the surface cortex of the brain, making it difficult for existing equipment to deal with deep lesions, and also difficult to deal with the current problem of lesion treatment with random distribution in multiple points, multiple surfaces, and multiple blocks. A dual-light source human brain photobiomodulation device based on near-infrared LED and laser is provided, which radiates specific human brain lesion areas with near-infrared light of a certain power and emission frequency to achieve relief and treatment of Alzheimer's disease, thereby solving the above problems.

[0006] The present invention provides a dual-light source human brain photobiomodulation device based on near-infrared LED and laser, comprising a multi-point laser unit and a multi-point LED unit. The multi-point laser unit is used to arrange a light source for outputting near-infrared laser corresponding to a therapeutic spectrum range at at least one point, and the multi-point LED unit is used to arrange a light source for outputting near-infrared light corresponding to a therapeutic spectrum range at at least one point. The multi-point laser unit and the multi-point LED unit both fit the outside of the human brain and have overlapping output functional areas.

[0007] The therapeutic spectrum range of laser phototherapy light source corresponds to near-infrared laser, and the therapeutic spectrum range of LED phototherapy light source corresponds to near-infrared light.

[0008] By overlapping the output areas of the functional areas, when the output areas of the functional areas overlap, the actual action areas of the laser unit and the LED unit can achieve continuous coverage of the surface and deep light sources in the three-dimensional space of the brain due to the direction of the output areas.

[0009] The irradiation areas of LED and laser are different. Generally, there is no overlap in the locations of various physical therapy sub-modules. In fact, the transcranial and transbrain propagation processes of light are complicated. At the same time, the irradiation positions and irradiation postures of multiple LED light sources and laser light sources are different. In actual physical therapy, there will be a phenomenon of energy coupling among multiple light sources. The energy coupling area is farther away from the main irradiation therapy area. The weaker light energy in this area causes some damaged brain cells to fail to reach the lower threshold of starting the repair mechanism, and the coupling of multiple light sources may enable the cells to reach the energy threshold of damaged repair, thereby enhancing the physical therapy effect to a certain extent.

[0010] The dual-light source human brain photobiomodulation device based on near-infrared LED and laser described in the present invention, as a preferred embodiment, also includes a power supply unit, a control unit and a frame. The power supply unit is electrically connected to the control unit, the multi-point laser unit and the multi-point LED unit. The control unit controls the multi-point laser unit and the multi-point LED unit. The frame is used to fix the multi-point laser unit and the multi-point LED unit.

[0011] The present invention describes a dual-light source human brain photobiomodulation device based on near-infrared LED and laser. As a preferred embodiment, the multi-point laser unit includes a linear laser phototherapy module and a point laser phototherapy module. The linear laser phototherapy module outputs linear laser, and the point laser phototherapy module outputs point laser. The linear laser phototherapy module and the point laser phototherapy module are respectively arranged on the outside of the human brain.

[0012] The present invention describes a dual-light source human brain photobiomodulation device based on near-infrared LED and laser. As a preferred embodiment, the linear laser phototherapy module is a module composed of several linear laser device modules, wherein each linear laser device realizes energy distribution uniformity and linear distribution of the laser diode output light through two groups of aspheric lenses and one group of gratings, respectively, and the final divergence angle of the light beam is 90°.

[0013] The point laser phototherapy module is composed of several point laser device modules, in which each point laser device achieves uniform energy distribution of Gaussian light emitted by the laser diode through two groups of aspheric lenses. The final divergence angle of the light beam is 30°, and the energy distribution uniformity is not less than 85%.

[0014] The multi-point LED unit is composed of several LED device modules, in which each LED device realizes the convergence of the output light of the LED light source and the uniform energy distribution of the light spot through 3 groups of aspherical lenses and 2 groups of microlens arrays. The final divergence angle of the light beam is 90°, and the energy distribution uniformity is not less than 90%.

[0015] The present invention describes a dual-light source human brain photobiomodulation device based on near-infrared LED and laser. As a preferred embodiment, the multi-point LED unit includes at least one pair of temporal lobe LED light therapy modules, at least one pair of frontal lobe LED light therapy modules and occipital lobe LED light therapy modules. The temporal lobe LED light therapy module irradiates the temporal lobe cortex, the frontal lobe LED light therapy module irradiates the back of the prefrontal cortex, and the occipital lobe LED light therapy module irradiates the occipital cortex.

[0016] The linear laser generated by the linear laser phototherapy module irradiates the posterior cingulate cortex.

[0017] The point laser phototherapy module includes at least one pair of temporal lobe laser phototherapy modules and at least one pair of frontal lobe laser phototherapy modules. Both the temporal lobe laser phototherapy module and the frontal lobe laser phototherapy module are used to accurately irradiate discretely distributed lesion target areas by combining the irregularly distributed lesion target area locations captured by medical imaging technology.

[0018] The dual-light source human brain photobiomodulation device based on near-infrared LED and laser described in the present invention, as a preferred embodiment, the frame includes a rear fulcrum, a rear beam, a rear optical therapy unit connecting seat, a main hinge, a front beam, a front optical therapy unit connecting seat and a front fulcrum, the rear beam is a curved beam structure, the two ends of the rear beam are respectively connected to the rear fulcrum and the main hinge, the rear optical therapy unit connecting seat is arranged in the middle of the rear beam for movably connecting the multi-point laser unit and the multi-point LED unit, the front beam is a curved beam structure, the two ends of the front beam are respectively connected to the front fulcrum and the main hinge, the front optical therapy unit connecting seat is arranged in the middle of the front beam for movably connecting the multi-point laser unit and the multi-point LED unit, the front beam and the rear beam have horizontal rotational freedom through the main hinge, the front fulcrum is used to contact the center of the forehead, and the rear fulcrum is used to contact the center of the back of the brain.

[0019] The present invention describes a dual-light source human brain photobiomodulation device based on near-infrared LED and laser. As a preferred embodiment, the control unit sends working instructions to the multi-point laser unit and the multi-point LED unit and transmits electrical energy to control the working status and working time of each module in the multi-point laser unit and each module in the multi-point LED unit according to the set mode.

[0020] The dual-light source human brain photobiomodulation device based on near-infrared LED and laser described in the present invention is, as a preferred embodiment, two temporal lobe LED phototherapy modules are movably mounted on the rear optical therapy unit connection seat on both sides of the rear beam axis through a joint arm structure, two frontal lobe LED phototherapy modules are movably mounted on the front optical therapy unit connection seat on both sides of the front beam axis through a joint arm structure, the occipital lobe LED phototherapy module is mounted on the inner side of the rear fulcrum, the linear laser phototherapy module is mounted on the inner side of the front beam or the rear beam body, the two temporal lobe laser phototherapy modules are movably mounted on the front optical therapy unit connection seat on both sides of the front beam axis through a joint arm structure, and the frontal lobe laser phototherapy module is mounted on the rear optical therapy unit connection seat on both sides of the rear beam axis through a joint arm structure.

[0021] The dual-light source human brain photobiomodulation device based on near-infrared LED and laser described in the present invention, as a preferred embodiment, the control mode of the control unit includes an alpha wave mode and a gamma wave mode,

[0022] The operating frequency of each therapy module in the alpha wave mode is 10Hz;

[0023] The operating frequency of each therapy module in the gamma wave mode is 40Hz;

[0024] In the α-wave mode and the γ-wave mode, the output duty cycle of the LED light energy is 50%, and the output duty cycle of the laser light energy is 35%.

[0025] The low-power near-infrared LED phototherapy module has the characteristics of large beam divergence angle, low power density and large irradiation area. It is suitable for physical therapy of the surface cortex of the brain, but has limited physical therapy effect on deep lesions. The laser diode has a small beam divergence angle and a pure light source. It can increase the output power within the safety threshold range, making it relatively high in transcranial penetration and suitable for physical therapy of deep lesions. As for single near-infrared LED technology or single near-infrared laser technology, neither can achieve physical therapy of large areas and deep lesions on the surface of the brain. The combination of multiple laser phototherapy modules and multiple LED phototherapy modules has formed a new technological innovation or technological advantage. With the optical module carrier that supports multi-region movement, non-invasive transcranial light source physical therapy of the surface cortex of the brain and deep lesions of the brain can be realized, which can effectively irradiate near-infrared light to multiple discrete deep and surface brain area lesions in the brain, and realize multi-target, precise and non-invasive neural intervention and regulation of the whole brain (cerebral cortex, deep nuclei) for elderly consciousness disorders, effectively improving the stimulation depth, stimulation accuracy and stimulation intervention effect. The present invention combines a multi-point LED phototherapy module and a multi-point near-infrared laser light source therapy module, assisted by the lesion target area location of medical imaging technology (such as CT, etc.) and guides the laser for precise irradiation through a multi-tentacle adjustable mechanical structure, thereby solving the technical status quo that the multi-point LED irradiation area is limited and it is difficult to effectively deal with the diseased tissue deep in the brain area.

[0026] The beneficial effects of the present invention are as follows:

[0027] (1) It can adapt to different head shapes and sizes and ensure that the main optical axis of the photoelectric module is parallel to the normal line of the head at the point of action. By adjusting the joint arm, the beam can cover the entire area of ​​the diseased brain;

[0028] (2) The optical system adopts a combination of aspheric lens and microlens array, which has the characteristics of good light source energy output stability and good spot energy distribution uniformity, improving the light energy transmission efficiency and physical therapy effect;

[0029] (3) The laser phototherapy module can complement the LED phototherapy module. The combination of the two light sources can form surface and deep light source coverage. Combined with the optical module carrier that supports multi-zone movement, the near-infrared light can effectively irradiate multiple lesion locations in the brain and the discrete deep and surface brain area lesion tissues. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 A schematic diagram of a dual-light source human brain photobiomodulation device based on near-infrared LED and laser;

[0031] Figure 2 A schematic diagram of a multi-point laser unit of a dual-light source human brain photobiomodulation device based on near-infrared LED and laser;

[0032] Figure 3 A schematic diagram of a multi-point LED unit of a dual-light source human brain photobiomodulation device based on near-infrared LED and laser;

[0033] Figure 4 A schematic diagram of a point-type laser phototherapy module of a dual-light source human brain photobiomodulation device based on near-infrared LED and laser;

[0034] Figure 5 This is a schematic diagram of the framework of a dual-light source human brain photobiomodulation device based on near-infrared LED and laser.

[0035] Reference numerals:

[0036] 1. Multi-point laser unit; 11. Linear laser phototherapy module; 12. Point laser phototherapy module; 121. Temporal lobe laser phototherapy module; 122. Frontal lobe laser phototherapy module; 2. Multi-point LED unit; 21. Temporal lobe LED phototherapy module; 22. Frontal lobe LED phototherapy module; 23. Occipital lobe LED phototherapy module; 3. Power supply unit; 4. Control unit; 5. Frame; 51. Rear fulcrum; 52. Rear beam; 53. Rear optical therapy unit connecting seat; 54. Main hinge; 55. Front beam; 56. Front optical therapy unit connecting seat; 57. Front fulcrum. DETAILED DESCRIPTION

[0037] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments.

[0038] Example 1

[0039] like Figure 1 As shown, a dual-light source human brain photobiomodulation device based on near-infrared LED and laser includes a multi-point laser unit 1, a multi-point LED unit 2, a power supply unit 3, a control unit 4 and a frame 5. The multi-point laser unit 1 is used to arrange a light source for outputting near-infrared laser corresponding to the physiotherapy spectrum range at at least one point, and the multi-point LED unit 2 is used to arrange a light source for outputting near-infrared light corresponding to the physiotherapy spectrum range at at least one point. The multi-point laser unit 1 and the multi-point LED unit 2 are both attached to the outside of the human brain and the output functional areas overlap. The power supply unit 3 is electrically connected to the control unit 4, the multi-point laser unit 1 and the multi-point LED unit 2. The control unit 4 controls the multi-point laser unit 1 and the multi-point LED unit 2. The frame 5 is used to fix the multi-point laser unit 1 and the multi-point LED unit 2.

[0040] The spectrum range of the light sources in the multi-point laser unit 1 and the multi-point LED unit 2 is 800-900 nm, and the operating frequency is selected between 10 Hz and 40 Hz according to different physical therapy needs.

[0041] The power supply unit 3 is the power supply of the device. In this embodiment, the output voltage of the power supply unit 3 is 5.0V DC.

[0042] The control modes of the control unit 4 include an α wave mode and a γ wave mode.

[0043] The operating frequency of each therapy module in the alpha wave mode is 10Hz;

[0044] The operating frequency of each therapy module in the gamma wave mode is 40Hz;

[0045] In the α-wave mode and the γ-wave mode, the output duty cycle of the LED light energy is 50%, and the output duty cycle of the laser light energy is 35%.

[0046] Furthermore, the system program sets the duration of a single physical therapy session to 20 minutes. If you need to stop using it in the middle of the session, you can turn off the physical therapy device by pressing the power button.

[0047] like Figure 2 As shown, the multi-point laser unit 1 includes a linear laser phototherapy module 11 and a point laser phototherapy module 12. The linear laser phototherapy module 11 outputs linear laser, and the point laser phototherapy module 12 outputs point laser. The linear laser phototherapy module 11 and the point laser phototherapy module 12 are respectively arranged on the outside of the human brain.

[0048] The linear laser phototherapy module 11 is a module composed of several linear laser device modules, wherein each linear laser device realizes the energy distribution uniformity and linear distribution of the laser diode output light through two groups of aspheric lenses and one group of gratings, and the final divergence angle of the light beam is 90°;

[0049] The point laser phototherapy module 12 is a module composed of several point laser device modules, wherein each point laser device achieves uniform energy distribution of Gaussian light emitted by the laser diode through two groups of aspheric lenses, the final divergence angle of the light beam is 30°, and the energy distribution uniformity is not less than 85%.

[0050] The multi-point LED unit 2 is a unit composed of several LED device modules, in which each LED device realizes the convergence of the output light of the LED light source and the uniform energy distribution of the light spot through 3 groups of aspherical lenses and 2 groups of microlens arrays. The final divergence angle of the light beam is 90°, and the energy distribution uniformity is not less than 90%.

[0051] like Figure 3As shown, the multi-point LED unit 2 includes at least one pair of temporal lobe LED light therapy modules 21, at least one pair of frontal lobe LED light therapy modules 22 and an occipital lobe LED light therapy module 23. The temporal lobe LED light therapy module 21 irradiates the temporal lobe cortex, the frontal lobe LED light therapy module 22 irradiates the back of the prefrontal cortex, and the occipital lobe LED light therapy module 23 irradiates the occipital cortex.

[0052] The linear laser generated by the linear laser phototherapy module 11 irradiates the posterior cingulate cortex.

[0053] like Figure 4 As shown, the point laser phototherapy module 12 includes at least one pair of temporal lobe laser phototherapy modules 121 and at least one pair of frontal lobe laser phototherapy modules 122. The temporal lobe laser phototherapy module 121 and the frontal lobe laser phototherapy module 122 are both used to accurately irradiate discretely distributed lesion target areas in combination with the irregularly distributed lesion target area positions captured by medical imaging technology.

[0054] like Figure 5 As shown, the frame 5 includes a rear fulcrum 51, a rear beam 52, at least one rear optical therapy unit connecting seat 53, a main hinge 54, a front beam 55, at least one front optical therapy unit connecting seat 56 and a front fulcrum 57. The rear beam 52 is a curved beam structure, and the two ends of the rear beam 52 are respectively connected to the rear fulcrum 51 and the main hinge 54. The rear optical therapy unit connecting seat 53 is arranged in the middle of the rear beam 52 for movably connecting the multi-point laser unit 1 and the multi-point LED unit 2. The front beam 55 is a curved beam structure, and the two ends of the front beam 55 are respectively connected to the front fulcrum 57 and the main hinge 54. The front optical therapy unit connecting seat 56 is arranged in the middle of the front beam 55 for movably connecting the multi-point laser unit 1 and the multi-point LED unit 2. The front beam 55 and the rear beam 52 have horizontal rotational freedom through the main hinge 54. The front fulcrum 57 is used to contact the center of the forehead, and the rear fulcrum 51 is used to contact the center of the back of the head. The front beam 55 is connected to the front fulcrum 57 through a rotating pair, and the rear beam 52 is connected to the rear fulcrum 51 through a rotating pair. In order to facilitate the storage and carrying of the device, the main hinge 54 can be rotated 180 degrees, and the device can be in a folded state by rotating the main hinge 54.

[0055] In this embodiment, the front optical therapy unit connecting seat 56 and the rear optical therapy unit connecting seat 53 are each installed with two pairs of joint arms. According to the needs of physical therapy, the front beam 55 and the rear beam 52 can be respectively installed with one or more groups of front optical therapy unit connecting seat 56 and rear optical therapy unit connecting seat 53, wherein the joint arms are divided into posterior temporal lobe joint arms, anterior temporal lobe joint arms, posterior frontal lobe joint arms and anterior frontal lobe joint arms.

[0056] In this embodiment, each articulated arm is composed of a shoulder joint, an upper arm, an elbow joint, a lower arm, a wrist joint and a tentacle, wherein the shoulder joint is the head end of the articulated arm, the tentacle is the end end of the articulated arm, the shoulder joint and the elbow joint are revolute pairs, and the wrist joint is a spherical pair.

[0057] Furthermore, the rotation angle of the shoulder joint is β=120°, and the rotation angle of the elbow joint as a revolute pair is 360°.

[0058] The two temporal lobe LED phototherapy modules 21 are movably installed on the rear optical therapy unit connecting seat 53 on both sides of the axis of the rear beam 52 through a joint arm structure, the two frontal lobe LED phototherapy modules 22 are movably installed on the front optical therapy unit connecting seat 56 on both sides of the axis of the front beam 55 through a joint arm structure, the occipital lobe LED phototherapy module 23 is installed on the inner side of the rear fulcrum 51, the linear laser phototherapy module 11 is installed on the inner side of the beam body of the rear beam 52, the two temporal lobe laser phototherapy modules 121 are movably installed on the front optical therapy unit connecting seat 56 on both sides of the axis of the front beam 55 through a joint arm structure, and the frontal lobe laser phototherapy module 122 is installed on the rear optical therapy unit connecting seat 53 on both sides of the axis of the rear beam 52 through a joint arm structure.

[0059] The control unit 4 sends working instructions to the multi-point laser unit 1 and the multi-point LED unit 2 and transmits electric energy, and controls the working state and working time of each module in the multi-point laser unit 1 and each module in the multi-point LED unit 2 according to the set mode.

[0060] The control modes of the control unit 4 include an α wave mode and a γ wave mode.

[0061] The operating frequency of each therapy module in the alpha wave mode is 10Hz;

[0062] The operating frequency of each therapy module in the gamma wave mode is 40Hz;

[0063] In the α-wave mode and the γ-wave mode, the output duty cycle of the LED light energy is 50%, and the output duty cycle of the laser light energy is 35%.

[0064] In the standard wearing state of the dual-light source human brain photobiomodulation device based on near-infrared LED and laser of this embodiment, the front fulcrum 57 acts on the center of the forehead, and the rear fulcrum 51 acts on the center of the back of the brain, and the clamping force generated by the front beam 55 and the rear beam 52 maintains the positioning stability of the frame 3 and the head; the occipital LED phototherapy module 23 installed in the rear fulcrum 51 irradiates the occipital cortex; the frontal LED phototherapy module 22 is fitted to the forehead epidermis through the stress of the frontal lobe joint arm, and the light beam is irradiated on the back of the frontal cortex; similarly, the temporal lobe LED phototherapy module 21 is fitted to the outer skin of the head corresponding to the temporal lobe, and the light beam is irradiated on the temporal cortex; the linear laser phototherapy module 11 is installed on the rear beam, and the distance between the linear laser phototherapy module 11 and the head epidermis is 2 to 3 cm, and the linear laser generated irradiates the posterior cingulate cortex; the position of the irregularly distributed lesion target area photographed by the auxiliary joint arm guided by the medical imaging technology is used to achieve precise irradiation of the discretely distributed lesion area.

[0065] Example 2

[0066] Different from Example 1, in this embodiment, the linear laser phototherapy module is installed on the inner side of the front beam or the rear beam.

[0067] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A dual-light source human brain photobiomodulation device based on near-infrared LED and laser, characterized in that: The invention comprises a multi-point laser unit (1) and a multi-point LED unit (2), wherein the multi-point laser unit (1) is used to arrange a light source for outputting near-infrared laser corresponding to the physiotherapy spectrum range at at least one point, and the multi-point LED unit (2) is used to arrange a light source for outputting near-infrared light corresponding to the physiotherapy spectrum range at at least one point, and the multi-point laser unit (1) and the multi-point LED unit (2) are both attached to the outer side of the human brain and have overlapping output functional areas; The multi-point laser unit (1) comprises a linear laser phototherapy module (11) and a point laser phototherapy module (12); the linear laser phototherapy module (11) outputs linear laser, and the point laser phototherapy module (12) outputs point laser; the linear laser phototherapy module (11) and the point laser phototherapy module (12) are respectively arranged on the outside of the human brain; The linear laser phototherapy module (11) is a module composed of a plurality of linear laser device modules, wherein each linear laser device realizes energy distribution uniformity and linear distribution of laser diode output light respectively through two groups of aspheric lenses and one group of gratings, and the final divergence angle of the light beam is 90°; The point-type laser phototherapy module (12) is a module composed of a plurality of point-type laser device modules, wherein each point-type laser device realizes uniform distribution of Gaussian light energy emitted by a laser diode through two groups of aspheric lenses, the final divergence angle of the light beam is 30°, and the uniformity of energy distribution is not less than 85%; The multi-point LED unit (2) comprises at least one pair of temporal lobe LED light therapy modules (21), at least one pair of frontal lobe LED light therapy modules (22) and an occipital lobe LED light therapy module (23); the temporal lobe LED light therapy module (21) irradiates the temporal lobe cortex, the frontal lobe LED light therapy module (22) irradiates the back of the prefrontal lobe cortex, and the occipital lobe LED light therapy module (23) irradiates the occipital lobe cortex.

2. According to claim 1, a dual-light source human brain photobiomodulation device based on near-infrared LED and laser, characterized in that: The dual-light source human brain photobiomodulation device based on near-infrared LED and laser further comprises a power supply unit (3), a control unit (4) and a frame (5); the power supply unit (3) is electrically connected to the control unit (4), the multi-point laser unit (1) and the multi-point LED unit (2); the control unit (4) controls the multi-point laser unit (1) and the multi-point LED unit (2); and the frame (5) is used to fix the multi-point laser unit (1) and the multi-point LED unit (2).

3. The dual-light source human brain photobiomodulation device based on near-infrared LED and laser according to claim 2, characterized in that: The multi-point LED unit (2) is a unit composed of several LED device modules, wherein each LED device realizes the convergence of the light emitted by the LED light source and the uniformity of the energy distribution of the light spot through three groups of aspherical lenses and two groups of microlens arrays, the final divergence angle of the light beam is 90°, and the uniformity of energy distribution is not less than 90%.

4. The dual-light source human brain photobiomodulation device based on near-infrared LED and laser according to claim 2, characterized in that: The linear laser phototherapy module (11) generates a linear laser to irradiate the posterior cingulate cortex; The point-type laser phototherapy module (12) comprises at least one pair of temporal lobe laser phototherapy modules (121) and at least one pair of frontal lobe laser phototherapy modules (122); the temporal lobe laser phototherapy module (121) and the frontal lobe laser phototherapy module (122) are both used to precisely irradiate discretely distributed lesion target areas in combination with irregularly distributed lesion target area locations photographed using medical imaging technology.

5. The dual-light source human brain photobiomodulation device based on near-infrared LED and laser according to claim 4, characterized in that: The frame (5) comprises a rear fulcrum (51), a rear beam (52), a rear optical therapy unit connection seat (53), a main hinge (54), a front beam (55), a front optical therapy unit connection seat (56) and a front fulcrum (57); the rear beam (52) is a curved beam structure; two ends of the rear beam (52) are respectively connected to the rear fulcrum (51) and the main hinge (54); the rear optical therapy unit connection seat (53) is arranged in the middle of the rear beam (52) for movably connecting the multi-point laser unit (1) and the multi-point LED unit (2) The front beam (55) is a curved beam structure, and the two ends of the front beam (55) are respectively connected to the front fulcrum (57) and the main hinge (54). The front optical therapy unit connection seat (56) is arranged in the middle of the front beam (55) for movably connecting the multi-point laser unit (1) and the multi-point LED unit (2). The front beam (55) and the rear beam (52) have horizontal rotational freedom through the main hinge (54). The front fulcrum (57) is used to contact the center of the forehead, and the rear fulcrum (51) is used to contact the center of the back of the head.

6. The dual-light source human brain photobiomodulation device based on near-infrared LED and laser according to claim 2, characterized in that: The control unit (4) sends working instructions to the multi-point laser unit (1) and the multi-point LED unit (2) and transmits electric energy, and controls the working state and working time of each module in the multi-point laser unit (1) and each module in the multi-point LED unit (2) according to a set mode.

7. The dual-light source human brain photobiomodulation device based on near-infrared LED and laser according to claim 5, characterized in that: The two temporal lobe LED phototherapy modules (21) are movably mounted on the rear optical therapy unit connection seat (53) on both sides of the axis of the rear beam (52) through a joint arm structure; the two frontal lobe LED phototherapy modules (22) are movably mounted on the front optical therapy unit connection seat (56) on both sides of the axis of the front beam (55) through a joint arm structure; the occipital lobe LED phototherapy module (23) is mounted on the inner side of the rear fulcrum (51); the linear laser phototherapy module (11) is mounted on the inner side of the body of the rear beam (52); the two temporal lobe laser phototherapy modules (121) are movably mounted on the front optical therapy unit connection seat (56) on both sides of the axis of the front beam (55) through a joint arm structure; and the frontal lobe laser phototherapy module (122) is mounted on the rear optical therapy unit connection seat (53) on both sides of the axis of the rear beam (52) through a joint arm structure.

8. The dual-light source human brain photobiomodulation device based on near-infrared LED and laser according to claim 6, characterized in that: The control modes of the control unit (4) include an alpha wave mode and a gamma wave mode, The operating frequency of each therapy module in the alpha wave mode is 10 Hz; The operating frequency of each physiotherapy module in the gamma wave mode is 40 Hz; In the α-wave mode and in the γ-wave mode, the output duty ratio of the LED light energy is 50%, and the output duty ratio of the laser light energy is 35%.

9. The dual-light source human brain photobiomodulation device based on near-infrared LED and laser according to claim 5, characterized in that: The two temporal lobe LED phototherapy modules (21) are movably mounted on the rear optical therapy unit connection seat (53) on both sides of the axis of the rear beam (52) through a joint arm structure; the two frontal lobe LED phototherapy modules (22) are movably mounted on the front optical therapy unit connection seat (56) on both sides of the axis of the front beam (55) through a joint arm structure; the occipital lobe LED phototherapy module (23) is mounted on the inner side of the rear fulcrum (51); the linear laser phototherapy module (11) is mounted on the inner side of the front beam (55); the two temporal lobe laser phototherapy modules (121) are movably mounted on the front optical therapy unit connection seat (56) on both sides of the axis of the front beam (55) through a joint arm structure; and the frontal lobe laser phototherapy module (122) is mounted on the rear optical therapy unit connection seat (53) on both sides of the axis of the rear beam (52) through a joint arm structure.

Images